专利检索 ap:("GALDERMA RESEARCH & DEVELOPMENT") AND inv:"Feriel Hacini-Rachinel" 第 1 页

1.

发明授权
NLRP3 inhibitors for the treatment of inflammatory skin disorders 有权

公开(公告)号：US10857123B2

公开(公告)日：2020-12-08

申请号：US16072686

申请日：2017-01-25

申请人： GALDERMA RESEARCH & DEVELOPMENT

发明人： Feriel Hacini-Rachinel

IPC分类号： A61K31/341 , A61P17/04 , A61P17/06 , A61K9/00 , A61K31/381 , A61K31/4184 , A61K31/18 , A61K31/473 , A61K31/357 , A61K31/404

摘要： The use of an NLRP3 inhibitor compound is described in the treatment of inflammatory skin disorders, in particular psoriasis and atopic dermatitis.